epirubicin has been researched along with Endometrial Neoplasms in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anwar, S; Barthakur, U; El-Modir, A; Fernando, I; Tirmazy, SH | 1 |
| Abraham, J; Basu, B; Brenton, J; Earl, H; Freeman, S; Gounaris, I; Hatcher, H; Hosking, K; Iddawela, M; Jimenez-Linan, M; Moyle, P; Parkinson, C; Sayal, K | 1 |
| Huang, X; Ren, Y; Shan, B; Shi, D; Wang, H; Wu, X | 1 |
| Baresic, T; Buonadonna, A; Canzonieri, V; Corona, G; Lara, DP; Miolo, G; Santeufemia, DA; Viel, A | 1 |
| Fors, M; Grenman, S; Kuoppala, T; Lehtovirta, P; Luukkaala, T; Mäenpää, J; Puistola, U; Salmi, T; Sipilä, P; Tomas, E | 1 |
| Egawa-Takata, T; Enomoto, T; Fujita, M; Kimura, T; Matsuzaki, S; Miyake, T; Miyatake, T; Ueda, Y; Yokoyama, T; Yoshino, K | 1 |
| Asada, M; Egawa-Takata, T; Enomoto, T; Fujita, M; Ito, K; Kimura, T; Kuragaki, C; Miyake, T; Miyatake, T; Morishige, K; Nagamatsu, M; Nakashima, R; Nishio, Y; Nishizaki, T; Ogita, K; Okazawa, M; Tsutsui, T; Ueda, Y; Wakimoto, A; Yamamoto, T; Yamasaki, M; Yoshino, K | 1 |
| Honda, J; Kamatani, N; Kubo, M; Nakamura, Y; Sasa, M; Srinivasan, Y; Takahashi, A; Uno, S; Zembutsu, H | 1 |
| Boccardo, F; Bruzzone, M; Franzone, P; Gadducci, A; Miglietta, L | 1 |
| Li, DP; Li, HQ; Li, QS; Lu, CH; Sheng, XG; Song, XR; Tang, L; Wang, XW | 1 |
| Enomoto, T; Fujita, M; Murata, Y; Nakashima, R | 1 |
| Nakahara, K; Ogino, T; Osanai, T; Tsuchiya, T | 1 |
| Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K; Ojima, Y; Seki, N | 1 |
| Ren, YL; Shen, L; Wang, HY; Yang, WT | 1 |
| Bamias, A; Giannopoulos, A; Gourgoulis, G; Mountzios, G; Papaiakovou, EE; Rodolakis, A; Vlahos, G; Voulgaris, Z | 1 |
| Aravantinos, G; Bafaloukos, D; Bozas, G; Dimopoulos, MA; Fountzilas, G; Kalofonos, H; Kosmidis, P; Papadimitriou, CA | 1 |
| Bertelli, G; Pronzato, P; Vaira, F; Vigani, A | 1 |
| Gabriele, A; Gorga, G; Landoni, F; Lissoni, A; Mangioni, C; Sessa, C; Tumolo, S | 1 |
| Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
| Ishibashi, T; Kaneko, M; Kitada, H; Kobayashi, T; Kohyama, A; Kuwae, C; Minaguchi, R; Ohtsuka, H; Ono, I | 1 |
| Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H | 1 |
| Bender, HG; Michel, RT; Mitze, M; Stegmüller, M; Vering, A | 1 |
| Armas, A; Asins Codoner, J; Calero, F; Iglesias, J; Jimeno, J; Mendana, J; Murillo, F; Rementería, A; Rodríguez-Escudero, F; Ugalde, F | 1 |
1 review(s) available for epirubicin and Endometrial Neoplasms
| Article | Year |
|---|---|
[Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Endometrial Neoplasms; Epirubicin; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Postoperative Care; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
11 trial(s) available for epirubicin and Endometrial Neoplasms
| Article | Year |
|---|---|
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate | 2015 |
Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Prospective Studies | 2016 |
Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Risk Factors; Survival Rate | 2008 |
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Paclitaxel; Remission Induction; Retrospective Studies | 2011 |
Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Endometrial Neoplasms; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Risk Factors; Treatment Outcome | 2004 |
Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Treatment Outcome; Uterus | 2007 |
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Endometrial Neoplasms; Epirubicin; Female; Greece; Humans; Injections, Intravenous; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Recurrence | 2008 |
A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Endometrial Neoplasms; Epirubicin; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Neoplasm Staging; Ovarian Neoplasms; Platelet Count | 1996 |
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Cervical Neoplasms | 1997 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
Epirubicin: clinical toxicity during the phase II program in endometrial and cervical cancer.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Endometrial Neoplasms; Epirubicin; Female; Heart; Humans; Leukopenia; Middle Aged; Spain; Uterine Cervical Neoplasms; Vomiting | 1992 |
11 other study(ies) available for epirubicin and Endometrial Neoplasms
| Article | Year |
|---|---|
Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Staging; Retrospective Studies | 2014 |
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxoles; Endometrial Neoplasms; Epirubicin; Female; Genes, BRCA2; Germ-Line Mutation; Humans; Ifosfamide; Liver Neoplasms; Middle Aged; Mutation, Missense; Sarcoma, Endometrial Stromal; Tetrahydroisoquinolines; Trabectedin | 2016 |
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Case-Control Studies; Cell Cycle Proteins; Cytoskeletal Proteins; Endometrial Neoplasms; Epirubicin; Female; Genome-Wide Association Study; Humans; Japan; Leukopenia; Linkage Disequilibrium; Liver Neoplasms; Male; Neoplasms; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Prognosis; Risk Factors | 2011 |
[Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Organoplatinum Compounds; Oxaliplatin | 2004 |
Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Carboplatin; Diphosphonates; Endometrial Neoplasms; Epirubicin; Female; Humans; Paclitaxel; Pamidronate | 2006 |
[Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Survival Rate; Uterine Neoplasms | 2006 |
Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Topotecan | 2008 |
[Intra-arterial infusion chemotherapy for advanced endometrial cancer before surgical treatment].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Mitomycin; Preoperative Care | 1998 |
Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Base Pair Mismatch; Breast Neoplasms; Carrier Proteins; Colorectal Neoplasms; Deoxycytidine; DNA Repair; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Epirubicin; Female; Gemcitabine; Humans; Intercalating Agents; Mitoxantrone; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |
Influence of chemotherapy on hormone receptor concentration in a xenotransplanted endometrial cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Mice; Mice, Nude; Mitomycins; Neoplasm Transplantation; Receptors, Estradiol; Receptors, Progesterone; Transplantation, Heterologous | 1992 |